Pharma and Biotech
Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -49.6% | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | 24.7 | n/a |
PEG | n/a | n/a |
Pr/Revenue | 11.3 | n/a |
Pr/Book | 3.2 |
Latest | F'cast | |
---|---|---|
Revenue | 48.6% | n/a |
PBT | n/a | n/a |
EPS | -52.2% | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-21 | 133.66 | (166.00) | 23.00p | 30.3 | n/a | n/a | n/a | 0.0% |
31-Dec-22 | 198.60 | (83.41) | 11.00p | 22.4 | n/a | -52% | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Issue of Equity and Total Voting Rights | 01-Jun-2023 | 15:00 | RNS |
London Calling Technology Update | 19-May-2023 | 07:00 | RNS |
Holding(s) in Company | 12-May-2023 | 13:30 | RNS |
Oxford Nanopore FY revenues grow | 17-Jan-2023 | ShareCast |
Director dealings: Oxford Nanopore exec sells ov... | 10-Oct-2022 | ShareCast |
Oxford Nanopore H1 revenues and profits surge | 13-Sep-2022 | ShareCast |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
11-May-23 | Transfer From | Clive Brown | 0.000p | 63 | £0.00 |
11-May-23 | Buy | Clive Brown | 236.00p | 63 | £148.68 |
11-May-23 | Transfer From | Timothy Cowper | 0.000p | 63 | £0.00 |
Currency | UK Pounds |
Share Price | 272.00p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 363.00 |
52 Week Low | 176.60 |
Volume | 0 |
Shares Issued | 827.50m |
Market Cap | £2,250.79m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
0 @ 0.000p |
CEO | Gurdial (Gordon) Sanghera |
CFO | Timothy Cowper |
You are here: research